This critically important legislation will get states the resources they need to fight the heroin and prescription opioid epidemic. It invests the $1 billion the President has repeatedly said is necessary to help communities that have seen far too many overdoses. It also responds to the Vice President’s call for a Moonshot in cancer research by investing $1.8 billion in new resources to transform cancer research and accelerate discoveries. Plus, it invests nearly $3 billion to continue the President’s signature biomedical research initiatives, the BRAIN and Precision Medicine Initiatives, over the next decade to tackle diseases like Alzheimer’s and create new research models to find cures and better target treatments.
H.R. 34 also takes important steps to improve mental health, including provisions that build on the work of the President's Mental Health and Substance Use Disorder Parity Task Force. It further advances the drug approval process by taking steps like modernizing clinical trial design and better incorporating patients’ voices into FDA’s decision-making processes. Like all comprehensive legislation, the bill is not perfect, and there are provisions the Administration would prefer were improved, but the legislation offers advances in health that far outweigh these concerns. The Senate should promptly pass this bill so that the President can sign it.